HER-2/neu oncogene amplification in cervical cancer studied by fluorescent in situ hybridization

scientific article published on 01 January 1999

HER-2/neu oncogene amplification in cervical cancer studied by fluorescent in situ hybridization is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1089/GTE.1999.3.237
P698PubMed publication ID10464675

P2093author name stringDas S
Feldman D
Mark HF
Samy M
Sun CL
Lathrop J
P2860cites workCytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridizationQ29616823
The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigenQ52827123
P433issue2
P304page(s)237-242
P577publication date1999-01-01
P1433published inGenetic Testing and Molecular BiomarkersQ15753742
P1476titleHER-2/neu oncogene amplification in cervical cancer studied by fluorescent in situ hybridization
P478volume3

Reverse relations

cites work (P2860)
Q42285872Gene amplification and immunohistochemical expression of ERBB2 and EGFR in cervical carcinogenesis. Correlation with cell-cycle markers and HPV presence
Q24792559HER2 expression in cervical cancer as a potential therapeutic target
Q33918707Loss of sequences on the short arm of chromosome 17 is a late event in squamous carcinoma of the cervix.
Q57218329Selection of HER-2/neu-positive tumor cells in early stage cervical cancer: implications for Herceptin-mediated therapy
Q53890793The use of trastuzumab in the treatment of hormone refractory prostate cancer; phase II trial.

Search more.